BioLineRx to Report 2024 Annual Results on March 31, 2025

Go back to BioLineRx to Report 2024 Annual Results on March 31, 2025
BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.70 --0 (-0%)
Previous Close $2.70    52 Week High $1.63 
Open $2.70    52 Week Low $0.71 
Day High $2.70    P/E N/A 
Day Low $2.70    EPS $0.00 
Volume 117       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.70 --0 (-0%)
Previous Close $2.70    52 Week High $1.63 
Open $2.70    52 Week Low $0.71 
Day High $2.70    P/E N/A 
Day Low $2.70    EPS $0.00 
Volume 117